semaglutide news october 26 2025 Semaglutide, a second-generation GLP-1 receptor agonist, was associated with significantly reduced body weight and other metabolic factors in adults with schizophrenia, prediabetes, and overweight/obesity compared with placebo, research from September Democratic lawmakers are pressing the

Medigap plans in Washington State help pay for the gaps in Original Medicare things like hospital copays and Part B coinsurance

Many trial participants showed continued weight loss at 48 weeks with no clear plateau

Many compounding pharmacies add B12 because it may help with energy levels and because some research suggests it supports overall metabolic health during weight loss

These medications work as an appetite suppressant in Oklahoma City, curbing your cravings and helping you maintain a calorie deficit, when you burn more calories than you consume, to help you lose weight

When discussing gastrointestinal side effects, including heartburn, with your prescriber, it is helpful to: Keep a symptom diary noting when symptoms occur, their severity, duration, and any potential triggers Report all concurrent medications and supplements , as some including non-steroidal anti-inflammatory drugs (NSAIDs) and certain antibiotics can independently worsen reflux or interact with gastrointestinal function [8] [9] Ask about dose titration options if symptoms are significantly affecting your quality of life Discuss whether a formal GORD assessment is warranted , particularly if symptoms are persistent your GP may consider Helicobacter pylori testing or referral for endoscopy based on NICE CKS and NG12 criteria Your prescriber may refer you to a gastroenterologist if symptoms are complex or do not resolve with standard management